These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6258106)
1. Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration. Tell G; Böhlen P; Schechter PJ; Koch-Weser J; Agid Y; Bonnet AM; Coquillat G; Chazot G; Fischer C Neurology; 1981 Feb; 31(2):207-11. PubMed ID: 6258106 [TBL] [Abstract][Full Text] [Related]
2. Effects of single doses of vigabatrin on CSF concentrations of GABA, homocarnosine, homovanillic acid and 5-hydroxyindoleacetic acid in patients with complex partial epilepsy. Menachem EB; Persson LI; Schechter PJ; Haegele KD; Huebert N; Hardenberg J; Dahlgren L; Mumford JP Epilepsy Res; 1988; 2(2):96-101. PubMed ID: 3143561 [TBL] [Abstract][Full Text] [Related]
3. The effect of gamma-vinyl GABA and gamma-acetylenic GABA on the concentration of homocarnosine in brain and CSF of the rat. Palfreyman MG; Böhlen P; Huot S; Mellet M Brain Res; 1980 May; 190(1):288-92. PubMed ID: 7378742 [No Abstract] [Full Text] [Related]
4. Increased gamma-aminobutyric acid (GABA), homocarnosine and beta-alanine in cerebrospinal fluid of patients treated with gamma-vinyl GABA (4-amino-hex-5-enoic acid). Grove J; Schechter PJ; Tell G; Koch-Weser J; Sjoerdsma A; Warter JM; Marescaux C; Rumbach L Life Sci; 1981 May; 28(21):2431-9. PubMed ID: 6789022 [No Abstract] [Full Text] [Related]
5. Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea. Bonnet AM; Tell G; Schechter PJ; Grove J; Saint-Hilaire MH; De Smet Y; Agid Y Mov Disord; 1987; 2(2):117-23. PubMed ID: 2973560 [TBL] [Abstract][Full Text] [Related]
7. Total GABA and homocarnosine in CSF as indices of brain GABA concentrations. Palfreyman MG; Huot S; Grove J Neurosci Lett; 1983 Feb; 35(2):161-6. PubMed ID: 6856194 [TBL] [Abstract][Full Text] [Related]
8. Levels of total gamma-aminobutyric acid (GABA), free GABA and homocarnosine in cerebrospinal fluid of epileptic patients before and during gamma-vinyl-GABA (vigabatrin) treatment. Pitkänen A; Matilainen R; Ruutiainen T; Riekkinen P J Neurol Sci; 1988 Dec; 88(1-3):83-93. PubMed ID: 3225631 [TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid GABA and seizure control with vigabatrin. Riekkinen PJ; Ylinen A; Halonen T; Sivenius J; Pitkanen A Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):87S-94S. PubMed ID: 2757914 [TBL] [Abstract][Full Text] [Related]
10. Effects of intraventricular gamma-acetylenic-GABA on GABA concentrations, GABA-T and GAD in several areas of the chick brain. Nisticò G; Di Giorgio RM; De Luca G; Di Perri R; Macaione S Monogr Neural Sci; 1980; 5():34-9. PubMed ID: 7322172 [TBL] [Abstract][Full Text] [Related]
11. Clinical and biochemical effects of gamma-vinyl Gaba in tardive dyskinesia. Gaio JM; Pollak P; Hommel M; Perret J J Neurol Neurosurg Psychiatry; 1987 Dec; 50(12):1674-8. PubMed ID: 3437301 [TBL] [Abstract][Full Text] [Related]
12. Antiseizure activity of gamma-acetylenic gamma-aminobutyric acid: a catalytic irreversible inhibitor of gamma-aminobutyric acid transaminase. Schechter PJ; Tranier Y; Jung MJ; Sjoerdsma A J Pharmacol Exp Ther; 1977 Jun; 201(3):606-12. PubMed ID: 864598 [TBL] [Abstract][Full Text] [Related]
13. Effect of gamma-vinyl GABA in Friedreich's ataxia. De Smet Y; Mear JY; Tell G; Schechter PH; Lhermitte F; Agid Y Can J Neurol Sci; 1982 May; 9(2):171-3. PubMed ID: 7104882 [TBL] [Abstract][Full Text] [Related]
15. Increased CSF gamma-aminobutyric acid after treatment with gamma-vinyl GABA. Grove J; Tell G; Schechter PJ; Koch-Weser J; Warter JM; Marescaux C; Rumbach L Lancet; 1980 Sep; 2(8195 pt 1):647. PubMed ID: 6107437 [No Abstract] [Full Text] [Related]
16. Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of gamma-acetylenic gaba and gamma-vinyl GABA, two irreversible GABA-T inhibitors. Schechter PJ; Tranier Y; Jung MJ; Böhlen P Eur J Pharmacol; 1977 Oct; 45(4):319-28. PubMed ID: 923642 [TBL] [Abstract][Full Text] [Related]
17. The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients. Ben-Menachem E; Persson LI; Schechter PJ; Haegele KD; Huebert N; Hardenberg J; Dahlgren L; Mumford JP Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):79S-85S. PubMed ID: 2474312 [TBL] [Abstract][Full Text] [Related]
18. Biochemical and clinical effects of gamma-vinyl GABA in patients with epilepsy. Schechter PJ; Hanke NF; Grove J; Huebert N; Sjoerdsma A Neurology; 1984 Feb; 34(2):182-6. PubMed ID: 6538006 [TBL] [Abstract][Full Text] [Related]
19. The effect of gamma-acetylenic GABA, an enzyme-activated irreversible inhibitor of GABA-transaminase, on dopamine pathways of the extrapyramidal and limbic systems. Palfreyman MG; Huot S; Lippert B; Schechter PJ Eur J Pharmacol; 1978 Aug; 50(4):325-36. PubMed ID: 699960 [TBL] [Abstract][Full Text] [Related]
20. Artifactual increases in the concentration of free GABA in samples of human cerebrospinal fluid are due to degradation of homocarnosine. Grove J; Schechter PJ; Tell G; Rumbach L; Marescaux C; Warter JM; Koch-Weser J J Neurochem; 1982 Oct; 39(4):1061-5. PubMed ID: 7119781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]